Search results
Added:
1 week ago
HRS Congress 2026 – Prof Lucas Boersma (St. Antonius Hospital, Nieuwegein, NL) joins us to discuss real-world periprocedural outcomes from the Enlighten post-market registry study evaluating the extravascular implantable cardioverter-defibrillator (EV-ICD) system, and how these compare to findings from pre-market clinical trials.The Enlighten study is an ongoing, global, prospective post-market…
View more
Added:
2 weeks ago
Added:
2 weeks ago
HRS Congress 2026 — Dr Robert Schaller (Penn Medicine, US) presents results from the ASCEND CSP IDE Study, evaluating the safety and effectiveness of a novel stylet-driven ICD lead designed specifically for left bundle branch area pacing — a step toward establishing CSP as a viable platform for patients requiring both defibrillation therapy and physiological pacing.This prospective, multicentre,…
View more
Added:
1 month ago
EHRA 2026, Paris — Dr Alexander Breitenstein (University Heart Center, Switzerland) joins us for a wide-ranging discussion on the evolving landscape of paediatric electrophysiology, exploring how advancing technologies, procedural refinements, and a growing evidence base are reshaping the long-term management of arrhythmias in children and young patients.Interview Questions:Can you introduce the…
View more
Added:
2 months ago
Start date:
Oct 23, 2024
This session covers the latest data on transvenous and subcutaneous ICD devices, focusing on shared decision-making and their practical applications in preventing sudden cardiac death. Moderated by Dr Blandine Mondésert (Montreal Heart Institute and University of Montreal, CA) and Dr Ulrika Birgersdotter-Green (University of California San Diego, US), this webinar delves into the long-term…
View more
Added:
8 months ago
Source:
Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of…
View more
Phantom Shocks in ICD Patients: State-of-the-art Review
Added:
1 year ago
Systematic Review
Added:
1 month ago
EHRA 2026 — Dr Francesco Santoro joins us to discuss findings from his meta-analysis of randomised controlled trials comparing catheter ablation with anti-arrhythmic drug therapy in patients with ventricular tachycardia and ischaemic heart disease.This meta-analysis pooled data from four RCTs enrolling 947 patients with ischaemic heart disease and ICD implantation, randomised to either catheter…
View more
Added:
1 week ago
HRS Congress 2026 — In this interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr Pasquale Santangeli (Cleveland Clinic, Ohio) about the largest single-center US experience with the Medtronic dual-energy lattice tip catheter for ventricular tachycardia (VT) ablation.This platform combines radiofrequency (RF) ablation and pulsed field…
View more